Merck sells biosimilars business to Fresenius

25th April 2017 Uncategorised 0

Merck has divested its biosimilars business to fellow German drugmaker Fresenius in a deal potentially worth 670 million euros.

More: Merck sells biosimilars business to Fresenius
Source: News